The drug combination sacubitril and valsartan, commonly known as Uperio, is effective in the treatment of symptomatic heart failure in patients with systolic dysfunction. Sacubitril is a prodrug that inhibits the enzyme neprilysin, which helps to dilate blood vessels and increase sodium secretion, while valsartan is an angiotensin II receptor blocker for vasodilatation and blood pressure reduction.